The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Revenues: for Q1 – 2024, revenues grew by 9.30%, reaching SAR 2,521.41 million, with an increase of SAR 214.54 million as compared to SAR 2,306.87 million in the corresponding quarter of the previous year, as a result of the growth in all group operating segments. Revenue growth for Q1 – 2024 was mainly driven by growth in both the hospital and pharmacy segments. The increase in the hospital segment’s number of patients has a positive correlation with the pharmacy segment sales increase compared to the similar quarter of the previous year. |
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | EBITDA for Q1 – 2024 increased by 9.36%, reaching SAR 681.12 million. The group maintained the same EBITDA margin at 27.01%, compared to 27.00% in the corresponding quarter of the previous year. Net Income for Q1 – 2024 increased by 12.61% to reach SAR 550.95 million, with an improved net income margin reaching 21.85% versus 21.21% for the corresponding quarter of the previous year. The increase was mainly driven by revenue growth due to the increase in the number of patients. |
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | Revenue grew 1.40% during Q1 – 2024 compared to the previous quarter, Q4 – 2023, driven by the growth in the number of patients. |
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | Net income attributable to the company’s shareholders Increased by 4.94% in Q1 – 2024 compared to the previous quarter Q4–2023, which was mainly due to the growth in revenue. |
Statement of the type of external auditor's report | Unmodified conclusion |
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | na |
Reclassification of Comparison Items | na |
Additional Information | na |
Attached Documents | |